All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, report not yet due | 2018-000143-12 | OXYTOCIN RESEARCH FOR BEHAVIORAL IMPAIRMENT SYMPTOMS IN DEMENTIA: Potential clinical efficacy of intranasal oxytocin in the treatment of frontotemporal dementia. A randomized, double-blind, placebo-co... | 2025-01-27 | not-yet-due |
Completed, but no date Terminated | 2018-002948-88 | Phase II study to evaluate the activity and safety of Cabozantinib in pretreated, advanced RET-reArranged non-small cell lung cancer patients: CRETA trial Studio di fase II per valutare l’attività ... | bad-data | |
Not reported | 2019-002672-13 | CPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS Trial). A randomized controlled trial La CPAP riduce l’ipossiemia dopo chirurgia cardiaca (CRHACS trial): studio randomizzato e controllato | 2023-11-30 | due-trials |
Completed, report not yet due | 2019-002799-15 | Efficacy of a very low-volume Polyethylene Glycole (PEG 1L) bowel preparation vs. low-volume (2L) and high-volume (4L) PEG-based preparations. A randomized controlled study. Efficacia di una prepar... | 2024-12-31 | not-yet-due |
Not reported | 2020-001308-40 | Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19 Intermediate dose enoxaparin in hospitalized patients with mode... | 2021-05-26 | due-trials |